Evaluation of the DPC IMMULITE random access immunoassay analyser

Area of Science:

• Clinical Chemistry
• Laboratory Medicine
• Immunodiagnostics

Background:

• Automated immunoassay analyzers are crucial for efficient and accurate diagnostic testing.
• The DPC-IMMULITE system offers random, immediate, and continuous access capabilities.
• Evaluation of new analytical platforms is essential to ensure their suitability for clinical use.

Purpose of the Study:

• To evaluate the analytical performance of the DPC-IMMULITE automated immunoassay analyser.
• To assess its suitability for testing a range of routine and non-routine analytes.
• To determine the system's reproducibility, sensitivity, and correlation with other established assays.

Main Methods:

• The IMMULITE analyser was evaluated using four panels of analytes: thyroid, fertility, tumor, and non-routine markers.
• Reproducibility was assessed for within-run and between-day imprecision.
• Analytical sensitivity, dilution linearity, and correlation with other immunoassay platforms were determined.
• Inter-laboratory comparison was conducted between two testing sites.

Main Results:

• Good within-run (2.3-15.9% CV) and between-day (3.7-24.6% CV) reproducibility was observed.
• Analytical sensitivity ranged from very sensitive to acceptable across assays.
• High correlation (r=0.931 to 0.994) was found with other assays, with exceptions for lutropin and parathyrin.
• Excellent inter-laboratory correlation (r=0.984 to 0.999) was achieved.

Conclusions:

• The DPC-IMMULITE system is suitable for automated immunoassay testing in random access mode.
• The analyser demonstrates reliable performance for both routine and non-routine diagnostic markers.
• The system's accuracy and precision support its use in clinical laboratory settings.